Erhan KELEŞ
Araştırma
Our research focuses on uncovering the molecular underpinnings of cancer biology and advancing precision therapeutics through integrative strategies combining oncology, chemical biology, and rational drug design. Our primary mission is to develop and characterize highly selective, potent, and metabolically stable small-molecule inhibitors targeting oncogenic signaling pathways.